Home
About
FAQ
History (16)
Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
Sustained therapeutic effect of an anti-inflammatory peptide encapsulated in nanoparticles on ocular vascular leakage in diabetic retinopathy.
Health insurers' financial performance and quality improvement expenditures in the Affordable Care Act's second year.
Unplanned excision of soft-tissue sarcomas: current concepts for management and prognosis.
The cost of biologics for psoriasis is increasing.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The cost of biologics for psoriasis is increasing.
Cheng J, Feldman SR. The cost of biologics for psoriasis is increasing. Drugs Context. 2014; 3:212266.
View in:
PubMed
authors with profiles
Steven R. Feldman MD, PhD